These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1605607)

  • 1. Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses.
    Shigeta S; Mori S; Baba M; Ito M; Honzumi K; Nakamura K; Oshitani H; Numazaki Y; Matsuda A; Obara T
    Antimicrob Agents Chemother; 1992 Feb; 36(2):435-9. PubMed ID: 1605607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.
    De Clercq E; Cools M; Balzarini J; Snoeck R; Andrei G; Hosoya M; Shigeta S; Ueda T; Minakawa N; Matsuda A
    Antimicrob Agents Chemother; 1991 Apr; 35(4):679-84. PubMed ID: 2069373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A colorimetric LDH assay for the titration of infectivity and the evaluation of anti-viral activity against ortho- and paramyxoviruses.
    Mori S; Watanabe W; Shigeta S
    Tohoku J Exp Med; 1995 Dec; 177(4):315-25. PubMed ID: 8928191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
    Leyssen P; Balzarini J; De Clercq E; Neyts J
    J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.
    Balzarini J; Lee CK; Schols D; De Clercq E
    Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
    Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A
    Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections.
    Wyde PR; Moore-Poveda DK; De Clercq E; Neyts J; Matsuda A; Minakawa N; Guzman E; Gilbert BE
    Antimicrob Agents Chemother; 2000 May; 44(5):1146-52. PubMed ID: 10770743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of infectious pancreatic necrosis virus (IPNV) replication.
    Jashés M; González M; López-Lastra M; De Clercq E; Sandino A
    Antiviral Res; 1996 Mar; 29(2-3):309-12. PubMed ID: 8739609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
    Ölschläger S; Neyts J; Günther S
    Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
    Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
    Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
    J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.
    Kirsi JJ; North JA; McKernan PA; Murray BK; Canonico PG; Huggins JW; Srivastava PC; Robins RK
    Antimicrob Agents Chemother; 1983 Sep; 24(3):353-61. PubMed ID: 6615611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
    Minakawa N; Matsuda A
    Curr Med Chem; 1999 Jul; 6(7):615-28. PubMed ID: 10390604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication.
    Jashés M; Mlynarz G; De Clercq E; Sandino AM
    Antiviral Res; 2000 Jan; 45(1):9-17. PubMed ID: 10774586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling.
    Krajczyk A; Kulinska K; Kulinski T; Hurst BL; Day CW; Smee DF; Ostrowski T; Januszczyk P; Zeidler J
    Antivir Chem Chemother; 2014 Jan; 23(4):161-71. PubMed ID: 23538746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents.
    Watanabe W; Konno K; Ijichi K; Inoue H; Yokota T; Shigeta S
    J Virol Methods; 1994 Jul; 48(2-3):257-65. PubMed ID: 7989442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin.
    Kirsi JJ; McKernan PA; Burns NJ; North JA; Murray BK; Robins RK
    Antimicrob Agents Chemother; 1984 Oct; 26(4):466-75. PubMed ID: 6517540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemistry and clinical applications of ribavirin.
    Gilbert BE; Knight V
    Antimicrob Agents Chemother; 1986 Aug; 30(2):201-5. PubMed ID: 2876677
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of protease inhibitors on replication of various myxoviruses.
    Hosoya M; Matsuyama S; Baba M; Suzuki H; Shigeta S
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1432-6. PubMed ID: 1510439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of subacute sclerosing panencephalitis virus by the antiviral agent ribavirin.
    Murphy MF
    J Infect Dis; 1978 Aug; 138(2):249-51. PubMed ID: 79625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.